Fermelanta, Inc.
PrivateLast Round
Series A
Aug 28, 2025
Total Funding Raised
$15.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fermelanta, Inc. is a biotechnology company that develops plant secondary metabolites using a microbial fermentation process for industrial raw materials and ingredients including medicines, cosmetics, or supplements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fermelanta, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Fermelanta, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2025 | ||||
| Seed | Jun 13, 2023 |
Key People
Founding team and executive leadership
Fermelanta, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Bridge | Series A, Seed |
| Keio Innovation Initiative | Series A |
| Universal Materials Incubator | Series A |
| Norinchukin Capital Co., Ltd. | Series A |
| Plug and Play Japan | Seed |
| Beyond Next Ventures | Seed, Series A |
| Mitsubishi UFJ Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2027
Construction of a commercial-scale mass-production plant to begin in early 2027.
- May 12, 2026
Monthly visitors grew 164% MoM, reaching 3.7K.
Fermelanta, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fermelanta, Inc.'s valuation, stock price, and market status.